Status:
COMPLETED
A Clinical Clinical Observation of CO2 Fractional Laser in Female Vaginal Repair
Lead Sponsor:
Xijing Hospital
Conditions:
Vaginal Atrophy
Eligibility:
FEMALE
25-75 years
Phase:
NA
Brief Summary
1. Vaginal atrophy is the most common indication in the treatment of vaginal rejuvenation. Its main manifestation is vaginal relaxation syndrome, which may be the early symptom of female pelvic floor ...
Detailed Description
1. Vaginal atrophy is the most common indication in the treatment of vaginal rejuvenation. Its main manifestation is vaginal relaxation syndrome, which may be the early symptom of female pelvic floor ...
Eligibility Criteria
Inclusion
- Married women aged 25-75 with improvement needs;
- Agree to participate in the experiment and sign the informed consent.
- Female sexual dysfunction patients;
- No other external treatment was performed before treatment at the lesion site.
- VTI instrument was used for intravaginal pressure test to assess urinary incontinence and vaginal senility caused by chronic muscle dysfunction
Exclusion
- Pregnant or lactating women;
- suffering from severe mental disorders, psychological disorders, personality disorders and major organ dysfunction;
- Patients with severe hematological diseases, Sjogren's syndrome, systemic and therapeutic site infections;
- Patients who took high doses of anticoagulants or hormones within one month;
- Laser allergy history, photosensitive reactor;
- Women with acute vaginitis or cervicitis;
- Pap smear positive patients;
- Female HIV (HIV), HPV (papillary virus), HSV (herpes simplex virus) positive patients;
- Use of antifungal drugs, vaginal administration, vaginal irrigation and female sprays in the past 30 days
- The condition of the visual field of laser surgery affected by ulceration and infection of the skin lesion
- Those who have undergone vaginal tightening surgery with other substances or means
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04492176
Start Date
August 1 2019
End Date
October 30 2020
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Derpartment of Xijing Hospital
Xi'an, Shaanxi, China, 710032